StockClub

SABSW

SABSWSAB Biotherapeutics, Inc.$ --
SAB Biotherapeutics, Inc.

SAB Biotherapeutics, Inc.

SABSW

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
0M USD
YoY -100.0%
Operating Income
-16M USD
YoY -57.6%
Net Income
-17M USD
YoY -48.0%
EPS
-2.39$
YoY -94.3%

Revenue

$0
FY2024 Q1$944,575
$944,575
Q1
FY2024 Q2$1.2M
$1.2M
Q2
FY2024 Q3$1.2M
$1.2M
Q3
FY2024 Q4$1.3M
$1.3M
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$0
$0
Q3
FY2025 Q4$0
$0
Q4
Actual
$-1.3M (-100.0%)

Net Income

$13.3M
FY2024 Q1$-5M
$-5M
Q1
FY2024 Q2$-12.4M
$-12.4M
Q2
FY2024 Q3$-22.7M
$-22.7M
Q3
FY2024 Q4$-34.1M
$-34.1M
Q4
FY2025 Q1$-5.2M
$-5.2M
Q1
FY2025 Q2$-15.3M
$-15.3M
Q2
FY2025 Q3$30.1M
$30.1M
Q3
FY2025 Q4$13.3M
$13.3M
Q4
Actual
+$47.4M (+138.9%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020
Actual:$55.2M
FY2020
$55.2M
FY2021MISS
Actual:$60.9M
Est:$67.9M
FY2021MISS
$60.9M
FY2022MISS
Actual:$23.9M
Est:$27.6M
FY2022MISS
$23.9M
FY2023BEAT
Actual:$2.2M
Est:$1.3M
FY2023BEAT
$2.2M
FY2024MISS
Actual:$1.3M
Est:$1.3M
FY2024MISS
$1.3M
FY2025MISS
Actual:$0
Est:$166,667
FY2025MISS
$0

Analyst Estimates